TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $41,245 | +47.3% | 41,295 | +162.3% | 0.00% | – |
| Q3 2022 | $28,000 | -26.3% | 15,742 | +19.2% | 0.00% | – |
| Q2 2022 | $38,000 | -87.1% | 13,201 | -79.1% | 0.00% | – |
| Q4 2021 | $294,000 | +209.5% | 63,142 | +464.1% | 0.00% | – |
| Q3 2021 | $95,000 | -83.9% | 11,193 | -68.9% | 0.00% | – |
| Q2 2021 | $591,000 | -77.1% | 36,000 | -69.2% | 0.00% | -100.0% |
| Q1 2021 | $2,583,000 | +63.8% | 116,940 | +129.4% | 0.00% | – |
| Q4 2020 | $1,577,000 | – | 50,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |